NCT04135820View on ClinicalTrials.gov

A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

March 25, 2020

Study Completion Date

March 25, 2020

Conditions

NSCLC

Interventions

DRUG

BPI-7711

BPI-7711 180 mg

Trial Locations (1)

200025

Shanghai Ninth People's Hospital, Shanghai

Sponsors

Lead Sponsor

Beta Pharma, Inc.

All Listed Sponsors

lead

Beta Pharma, Inc.

INDUSTRY

NCT04135820 - A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711 | Biotech Hunter | Biotech Hunter